TNF-alpha protease inhibitors (Immunex)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTNF-alpha protease inhibitors (Immunex)
Drug Alias NameTAPI (Immunex)TAPI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitorsTumor necrosis factor α inhibitors
TargetsProteaseTumor necrosis factor α
Therapy Area/IndicationsShockInflammationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunex Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth-AyerstImmunex Corp
Active IndicationsN/A
Inactive IndicationsShockInflammationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A